Prostate Cancer Screening
Authors:
Open Access
- 31 December 2006
- book chapter
- Published by Springer Nature
- Vol. 175, 65-81
Abstract
Prostate cancer is a major healthcare problem worldwide, especially in the industrialized countries of the Western world. Prostate cancer has become the most common type of cancer among men and is the second leading cause of years of life lost from cancer in males [58]. Incidence estimates for the year 2000 indicate prostate cancer newly affected 542,990 men worldwide that year, 204,313 of whom have since died. Early detection and treatment of prostate cancer could theoretically reduce the burden of this potentially disabling and deadly disease. However, because no conclusive, direct evidence demonstrates that early detection and treatment improve length or quality of life, the value of prostate cancer screening remains controversial.Keywords
This publication has 55 references indexed in Scilit:
- Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mLUrology, 2005
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2005
- 20-Year Outcomes Following Conservative Management of Clinically Localized Prostate CancerJAMA, 2005
- Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reductionThe Prostate, 1999
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998
- CLINICAL GUIDELINE: PART 1: Early Detection of Prostate Cancer: Part IAnnals of Internal Medicine, 1997
- Comparison of Prostate Specific Antigen Concentration Versus Prostate Specific Antigen Density in the Early Detection of Prostate Cancer: Receiver Operating Characteristic CurvesJournal of Urology, 1994
- Screening for Prostatic Carcinoma with Prostate Specific Antigen: Results of the Second YearJournal of Urology, 1993
- Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseJAMA, 1992
- Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate CancerJournal of Urology, 1992